Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Latest filing published 18 Sept 2024 for Silk Road Medical Inc.
Filing timeline
BuySaleChas McKhann
Insider track record
Disclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Chas McKhann: trading record in brief
Chas McKhann is a declared insider at 2 companies (chief executive); the most frequent names are Apollo Endosurgery, Inc. and Silk Road Medical Inc. In total, 15 filings cover trades dated from 10 March 2021 to 17 September 2024.
Sales make up the whole of the open-market record (6 sales, €863k). Besides market trades, the filings include 6 share grants.
The record was last updated on 18 September 2024 with a transaction in Silk Road Medical Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Chas McKhann
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
722,396 sharesCommon StockSEC:0001140361-24-041406:0
110,313 shares0Common StockSEC:0001593968-24-000432:0
612,083 shares0Common StockSEC:0001593968-23-001398:0
689,880 sharesCommon StockSEC:0001251769-23-000027:0
112,607 shares0Common StockSEC:0001251769-22-000053:0
66,553 shares@ US$5.4269.8% of flowCommon StockSEC:0001251769-22-000036:0
21,156 shares@ US$8.2115.9% of flowCommon StockSEC:0001251769-21-000107:0
21,156 shares@ US$8.2130.2% of flowCommon StockSEC:0001251769-21-000105:0
8 of 8 declarations
